ClinicalTrials.Veeva

Menu

PENG Block Versus Fascia Iliaca Block for Pre- and Post-Operative Analgesia in Elderly Patients With Hip Fracture

Z

Zagazig University

Status

Unknown

Conditions

Hip Fractures

Treatments

Drug: Fentanyl
Procedure: Facia Iliaca block
Procedure: Pericapsular nerve Group block

Study type

Interventional

Funder types

Other

Identifiers

NCT04564326
6228/20-7-2020

Details and patient eligibility

About

Clinical controled trial to compare between pericapsular Nerve Group Block and Fascia Iliaca Block to find the best way to provide analgesia for elderly patients with hip fracture in the pre- and post-operative periods.

Full description

Pain is a major problem that has to be dealt with in case of hip fracture, as it resembles an obstacle for examination, positioning for receiving neuroaxial anesthesia and postoperative mobility and physiotherapy.

With the introduction of ultrasound in regional anesthesia and peripheral nerve blocks, regional analgesia float to the surface as a substitute for opioids with less side effects. Of the many techniques to provide regional analgesia for hip fractures; fascia iliaca block was widely used with good results. In 2018 Pericapsular Nerve Group Block was introduced to provide regional analgesia for hip fractures with interesting results.

In this study the investigators are going to compare Pericapsular Nerve Group Block and Fascia Iliaca Block to find the best way to provide analgesia for elderly patients with hip fracture in the pre- and post-operative periods.

Enrollment

51 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient acceptance.
  2. Accepted mental state of the patient.
  3. Gender: both sexes.
  4. Age above 65 years old.
  5. Body mass index 18.5-35 kg/m2.
  6. ASA physical status II and III.
  7. Unilateral hip fracture assigned for surgical fixation.
  8. Expected duration of surgery ≤ 3 hours.

Exclusion criteria

  1. Associated trauma or multiple fractures.
  2. Peripheral neuropathy.
  3. Coagulopathy.
  4. Infection at site of injection.
  5. Allergy to the drugs used in the study.
  6. Advanced kidney, liver or heart disease.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

51 participants in 3 patient groups

Group C
Active Comparator group
Description:
Patients will be assigned to receive opioids analgesia before spinal anesthesia in the form of intravenous fentanyl in a dose of 1mic/kg divided into two boluses with 5 minutes interval in between before positioning the patient for spinal anesthesia.
Treatment:
Drug: Fentanyl
Group P
Experimental group
Description:
Patients will be assigned to receive Pericapsular Nerve Group Block (PENG Block) before positioning the patient for spinal anesthesia.
Treatment:
Procedure: Pericapsular nerve Group block
Group F
Experimental group
Description:
Patients will be assigned to receive Fascia Iliaca Block (F.I Block) before positioning for spinal anesthesia.
Treatment:
Procedure: Facia Iliaca block

Trial documents
1

Trial contacts and locations

0

Loading...

Central trial contact

khaled M Mohamed, Master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems